4.7 Article

In vitro pharmacological profile of PHA-022121, a small molecule bradykinin B2 receptor antagonist in clinical development

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Allergy

Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation

Konrad Bork et al.

Summary: The study identified a novel disease-linked mutation for HAEnCI using whole exome sequencing, which affects HS biosynthesis and likely disrupts cell surface interactions of key players in angioedema formation.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Chemistry, Medicinal

A Robust Bioassay of the Human Bradykinin B2 Receptor That Extends Molecular and Cellular Studies: The Isolated Umbilical Vein

Francois Marceau et al.

Summary: Bradykinin (BK) plays various roles in the body, and the clinical applications of B2R antagonists are still under investigation. The classical smooth muscle contractility assay is crucial for studying drug potency. The use of the isolated human umbilical vein in experiments allows for verification of different types of drugs' effects on B2R.

PHARMACEUTICALS (2021)

Article Pharmacology & Pharmacy

In VitroPharmacological Profile of a New Small Molecule Bradykinin B(2)Receptor Antagonist

Anne Lesage et al.

FRONTIERS IN PHARMACOLOGY (2020)

Editorial Material Chemistry, Medicinal

A primer of deuterium in drug design

Sarah Cargnin et al.

FUTURE MEDICINAL CHEMISTRY (2019)

Review Genetics & Heredity

Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics

Itahisa Marcelino-Rodriguez et al.

FRONTIERS IN GENETICS (2019)

Article Chemistry, Medicinal

Applications of Deuterium in Medicinal Chemistry

Tracey Pirali et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Hematology

Hereditary angioedema: the plasma contact system out of control

S. De Maat et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Article Pharmacology & Pharmacy

Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2 receptor antagonist

A. Faussner et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)